Two pharmaceutical-grade forms of amygdalin — same active compound, different delivery formats. Covers specifications, storage, handling, and logistics. No medical recommendations are made.
Specifications
| Oral Tablets | Injectable Solution | |
|---|---|---|
| Active compound | Amygdalin (crystallised powder in tablet matrix) | Amygdalin (dissolved in sterile aqueous solution) |
| Strength / unit | 100 mg or 500 mg per tablet | 3,000 mg per 10 ml vial (300 mg/ml) |
| Physical form | Compressed solid tablet · off-white to cream | Clear to pale-yellow sterile aqueous solution |
| Route | Oral (swallowed) | Parenteral — professional handling required |
| Packaging | 100 tablets · amber/HDPE bottle · desiccant sachet | Single-use glass vials · individually sealed |
| Storage | Cool, dry place · 15–25°C · away from light | Refrigerated 2–8°C · cold-chain shipping available |
| Shelf life | Per COA date · typically 2 years from manufacture | Per COA date · refrigeration critical for stability |
| Shipping | Standard international · no special handling | Cold-chain packaging available · customs considerations apply |
| COA provided | Yes — per lot · available on request | Yes — per lot · available on request |
Format Profiles
Novodalin® · solid dose
Novodalin® · Krebs method · parenteral
TJ Supply — Since 2001
All Novodalin® products are HPLC-verified to ≥98% purity and ship with a Certificate of Analysis per lot. Choose the format that fits your protocol.
This page describes the physical and logistical specifications of each product format. No medical advice, dosage recommendations, or treatment protocols are made. Amygdalin/Laetrile is not FDA-approved to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Product specifications subject to change — verify with current COA documentation.
